title: Interventional nutrition for cardiac disease.
abstract: Animals with cardiac disease can have a variety of nutritional alterations for which interventional nutrition can be beneficial. Deviation from optimal body weight, both obesity and cachexia, is a common problem in cardiac patients and adversely affects the animal. Methods for maintaining optimal weight are important for good quality of life in dogs and cats with cardiac disease. Providing proper diets to prevent excess intake of sodium and chloride also is important, but severe salt restriction may not be necessary until later stages of disease. Certain nutrient deficiencies may play a role in the pathogenesis or complications of cardiac disease, but nutrients also may have effects on cardiac disease which are above and beyond their nutritional effects (nutritional pharmacology). Supplementation of nutrients such as taurine, carnitine, coenzyme Q10, and omega-3 polyunsaturated fatty acids may have benefits in dogs or cats with cardiac disease through a number of different mechanisms. By addressing each of these areas maintaining optimal weight, avoiding nutritional deficiencies and excesses, and providing the benefits of nutritional pharmacology, optimal patient management can be achieved.
authors.affiliation: Department of Clinical Sciences, School of Veterinary Medicine, Tufts University, North Grafton, MA 01536, USA.
authors.forename: L M
authors.initials: LM
authors.lastname: Freeman
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000008:administration & dosage; D002100:Cachexia / Q000209:etiology / Q000517:prevention & control / Q000662:veterinary; D002371:Cat Diseases / Q000178:diet therapy; D002415:Cats; D003067:Coenzymes; D019587:Dietary Supplements; D004283:Dog Diseases / Q000178:diet therapy; D004285:Dogs; D015525:Fatty Acids, Omega-3 / Q000008:administration & dosage; D006331:Heart Diseases / Q000150:complications / Q000178:diet therapy* / Q000662:veterinary*; D008275:Magnesium Deficiency / Q000150:complications; D011191:Potassium Deficiency / Q000150:complications; D013654:Taurine / Q000172:deficiency; D014451:Ubiquinone / Q000008:administration & dosage / Q000031:analogs & derivatives; D014815:Vitamins / Q000008:administration & dosage
chemical_list: D000975:Antioxidants; D003067:Coenzymes; D015525:Fatty Acids, Omega-3; D014815:Vitamins; D014451:Ubiquinone; D013654:Taurine; C024989:coenzyme Q10